Search Results - "Sesboüé, Richard"

Refine Results
  1. 1
  2. 2

    Follow-up of Bronchial Precancerous Lesions and Carcinoma in Situ Using Fluorescence Endoscopy by BOTA, SUZANA, AULIAC, JEAN-BERNARD, PARIS, CHRISTOPHE, METAYER, JOSETTE, SESBOUE, RICHARD, NOUVET, GEORGES, THIBERVILLE, LUC

    “…Little is known about the natural history of precancerous bronchial lesions. Histological changes occurring in 416 bronchial intraepithelial lesions (104…”
    Get full text
    Journal Article
  3. 3

    Metastatic colorectal cancer KRAS genotyping in routine practice: results and pitfalls by Lamy, Aude, Blanchard, France, Le Pessot, Florence, Sesboüé, Richard, Di Fiore, Frédéric, Bossut, Jessie, Fiant, Elodie, Frébourg, Thierry, Sabourin, Jean-Christophe

    Published in Modern pathology (01-08-2011)
    “…KRAS genotyping is mandatory before anti-epidermal growth factor receptor monoclonal antibody therapy in metastatic colorectal cancer, which is the second…”
    Get full text
    Journal Article
  4. 4

    Inactivation of the RRB1-Pescadillo pathway involved in ribosome biogenesis induces chromosomal instability by KILLIAN, Audrey, LE MEUR, Nathalie, SESBOÜE, Richard, BOURGUIGNON, Jeannette, BOUGEARD, Gaëlle, GAUTHEROT, Julien, BASTARD, Christian, FREBOURG, Thierry, FLAMAN, Jean-Michel

    Published in Oncogene (11-11-2004)
    “…Since chromosomal instability (CIN) is a hallmark of most cancer cells, it is essential to identify genes whose alteration results into this genetic…”
    Get full text
    Journal Article
  5. 5

    Overexpression of B-type cyclins alters chromosomal segregation by SARAFAN-VASSEUR, Nasrin, LAMY, Aude, BOURGUIGNON, Jeannette, LE PESSOT, Florence, HIETER, Philip, SESBOÜE, Richard, BASTARD, Christian, FREBOURG, Thierry, FLAMAN, Jean-Michel

    Published in Oncogene (21-03-2002)
    “…To identify genes which overexpression results into chromosomal instability (CIN), we developed a biological approach based on a yeast indicator strain in…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Predictive Survival Markers in Patients with Surgically Resected Non-Small Cell Lung Carcinoma by Moldvay, J, Scheid, P, Wild, P, Nabil, K, Siat, J, Borrelly, J, Marie, B, Farré, G, Labib, T, Pottier, G, Sesboüé, R, Bronner, C, Vignaud, J M, Martinet, Y, Martinet, N

    Published in Clinical cancer research (01-03-2000)
    “…Among patients with resected non-small cell lung carcinoma, about 50% will present a tumor recurrence. Thus, it would be of major importance to be able to…”
    Get full text
    Journal Article
  8. 8

    Photodynamic therapy using methylene blue in lung adenocarcinoma xenograft and hamster cheek pouch induced squamous cell carcinoma by Obstoy, Bérengère, Salaun, Mathieu, Bohn, Pierre, Veresezan, Liana, Sesboué, Richard, Thiberville, Luc

    Published in Photodiagnosis and photodynamic therapy (01-09-2016)
    “…Highlights • Methylene blue (MB) is evaluated as a photodynamic agent for cancer treatment of lung adenocarcinoma xenograft and Hamster cheek pouch induced…”
    Get full text
    Journal Article
  9. 9

    Drastic Effect of Germline TP53 Missense Mutations in Li-Fraumeni Patients by Zerdoumi, Yasmine, Aury-Landas, Juliette, Bonaïti-Pellié, Catherine, Derambure, Céline, Sesboüé, Richard, Renaux-Petel, Mariette, Frebourg, Thierry, Bougeard, Gaëlle, Flaman, Jean-Michel

    Published in Human mutation (01-03-2013)
    “…ABSTRACT In contrast to other tumor suppressor genes, the majority of TP53 alterations are missense mutations. We have previously reported that in the…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Real-time molecular optical micro-imaging of EGFR mutations using a fluorescent erlotinib based tracer by Patout, Maxime, Guisier, Florian, Brune, Xavier, Bohn, Pierre, Romieu, Anthony, Sarafan-Vasseur, Nasrin, Sesboüé, Richard, Renard, Pierre-Yves, Thiberville, Luc, Salaün, Mathieu

    Published in BMC pulmonary medicine (07-01-2019)
    “…EGFR mutations are routinely explored in lung adenocarcinoma by sequencing tumoral DNA. The aim of this study was to evaluate a fluorescent-labelled erlotinib…”
    Get full text
    Journal Article
  12. 12

    Molecular Predictive Factors for Progression of High-Grade Preinvasive Bronchial Lesions by Salaun, Mathieu, Sesboue, Richard, Moreno-Swirc, Sophie, Metayer, Josette, Bota, Suzanna, Bourguignon, Jeannette, Thiberville, Luc

    “…The outcome of precancerous bronchial lesions is not well known, and their management is subject to controversy. Many molecular alterations are present in…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15

    Aberrant methylation of the CDKN2a/p16INK4a gene promoter region in preinvasive bronchial lesions: A prospective study in high‐risk patients without invasive cancer by Lamy, Aude, Sesboüé, Richard, Bourguignon, Jeannette, Dautréaux, Brigitte, Métayer, Josette, Frébourg, Thierry, Thiberville, Luc

    Published in International journal of cancer (10-07-2002)
    “…Among the identified factors involved in malignant transformation, abnormal methylation of the CDKN2A/p16INK4a gene promoter has been described as an early…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Hyaluronectin modulation of lung metastasis in nude mice by Paris, Sébastien, Sesboüé, Richard, Chauzy, Claude, Maingonnat, Catherine, Delpech, Bertrand

    Published in European journal of cancer (1990) (01-12-2006)
    “…Hyaluronectin (HN) is a glycoprotein with a high affinity to hyaluronic acid (HA) and known to be a component of the extracellular matrix of tumours. Clinical…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Metastasis models: the green fluorescent revolution? by Paris, Sébastien, Sesboüé, Richard

    Published in Carcinogenesis (New York) (01-12-2004)
    “…Metastases are the leading cause of treatment failure and death of patients affected by malignant tumors, which makes them a major therapeutic target. During…”
    Get full text
    Journal Article
  20. 20